RecruitingPhase 4NCT06406010

Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

A Blinded Randomized Study Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy


Sponsor

Matias Vested

Enrollment

90 participants

Start Date

Aug 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Patients ≥ 18 years old
  • Informed consent
  • Scheduled for periacetabular osteotomy under general anesthesia with intubation
  • American Society of Anesthesiologists (ASA) physical status classification I to III
  • Can read and understand Danish

Exclusion Criteria3

  • Known allergy to ropivacaine
  • Daily use of opioids, gabapentin or tricyclic antidepressant (regardless of dose) within the last four weeks prior to surgery
  • Contraindications to Celocoxib, NSAIDs or paracetamol

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRopivacaine 5mg/ml 20ml

administered in a pericapsular nerve group (PENG) block

DRUGSaline 0.9%

administered in a pericapsular nerve group (PENG) block


Locations(1)

Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06406010


Related Trials